Literature DB >> 25726060

Endoscopic and operative palliation strategies for pancreatic ductal adenocarcinoma.

Alexander Stark1, O Joe Hines2.   

Abstract

Malignant biliary obstruction, duodenal, and gastric outlet obstruction, and tumor-related pain are the complications of unresectable pancreatic adenocarcinoma that most frequently require palliative intervention. Surgery involving biliary bypass with or without gastrojejunostomy was once the mainstay of treatment in these patients. However, advances in non-operative techniques-most notably the widespread availability of endoscopic biliary and duodenal stents-have shifted the paradigm of treatment away from traditional surgical management. Questions regarding the efficacy and durability of endoscopic stents for biliary and gastric outlet obstruction are reviewed and demonstrate high rates of therapeutic success, low rates of morbidity, and decreased cost. Surgery remains an effective treatment modality, and still produces the most durable relief in appropriately selected patients.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2014        PMID: 25726060     DOI: 10.1053/j.seminoncol.2014.12.014

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  12 in total

Review 1.  Supportive care in pancreatic ductal adenocarcinoma.

Authors:  B Laquente; A Calsina-Berna; A Carmona-Bayonas; P Jiménez-Fonseca; I Peiró; A Carrato
Journal:  Clin Transl Oncol       Date:  2017-06-13       Impact factor: 3.405

2.  [Palliative therapy concepts for pancreatic carcinoma].

Authors:  M Brunner; R Grützmann; G F Weber
Journal:  Chirurg       Date:  2018-09       Impact factor: 0.955

Review 3.  Palliative Care for Pancreatic and Periampullary Cancer.

Authors:  Jennifer A Perone; Taylor S Riall; Kelly Olino
Journal:  Surg Clin North Am       Date:  2016-12       Impact factor: 2.741

4.  Endoscopic ultrasound-guided choledochoduodenostomy with a lumen-apposing, self-expandable fully covered metal stent for palliative biliary drainage.

Authors:  Joshua Blake French; Adam Wesley Coe; Rishi Pawa
Journal:  Clin J Gastroenterol       Date:  2016-03-08

5.  Utilization and trends in palliative therapy for stage IV pancreatic adenocarcinoma patients: a U.S. population-based study.

Authors:  Audrey S Kulaylat; Katelin A Mirkin; Christopher S Hollenbeak; Joyce Wong
Journal:  J Gastrointest Oncol       Date:  2017-08

Review 6.  Pancreatic cancer-A disease in need: Optimizing and integrating supportive care.

Authors:  Gordon T Moffat; Andrew S Epstein; Eileen M O'Reilly
Journal:  Cancer       Date:  2019-08-05       Impact factor: 6.860

7.  Stomach-partitioning gastrojejunostomy is better than conventional gastrojejunostomy in palliative care of gastric outlet obstruction for gastric or pancreatic cancer: a meta-analysis.

Authors:  Dionigi Lorusso; Aurore Giliberti; Margherita Bianco; Giulio Lantone; Gioacchino Leandro
Journal:  J Gastrointest Oncol       Date:  2019-04

8.  SEOM Clinical Guideline for the treatment of pancreatic cancer (2016).

Authors:  R Vera; E Dotor; J Feliu; E González; B Laquente; T Macarulla; E Martínez; J Maurel; M Salgado; J L Manzano
Journal:  Clin Transl Oncol       Date:  2016-11-28       Impact factor: 3.405

9.  Consensus guidelines for diagnosis, treatment and follow-up of patients with pancreatic cancer in Spain.

Authors:  M Hidalgo; R Álvarez; J Gallego; C Guillén-Ponce; B Laquente; T Macarulla; A Muñoz; M Salgado; R Vera; J Adeva; I Alés; S Arévalo; J Blázquez; A Calsina; A Carmona; E de Madaria; R Díaz; L Díez; T Fernández; B G de Paredes; M E Gallardo; I González; O Hernando; P Jiménez; A López; C López; F López-Ríos; E Martín; J Martínez; A Martínez; J Montans; R Pazo; J C Plaza; I Peiró; J J Reina; A Sanjuanbenito; R Yaya; Alfredo Carrato
Journal:  Clin Transl Oncol       Date:  2016-12-19       Impact factor: 3.405

Review 10.  KRAS Mutant Pancreatic Cancer: No Lone Path to an Effective Treatment.

Authors:  Daniel Zeitouni; Yuliya Pylayeva-Gupta; Channing J Der; Kirsten L Bryant
Journal:  Cancers (Basel)       Date:  2016-04-18       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.